Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders

The effector functions of T lymphocytes are responsible for most autoimmune disorders and act by directly damaging tissues or by indirectly promoting inflammation and antibody responses. Co-stimulatory and co-inhibitory T cell receptor molecules are the primary pharmacological targets that enable in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanhove, Bernard, Poirier, Nicolas, Fakhouri, Fadi, Laurent, Laetitia, ’t Hart, Bert, Papotto, Pedro H., Rizzo, Luiz V., Zaitsu, Masaaki, Issa, Fadi, Wood, Kathryn, Soulillou, Jean-Paul, Blancho, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698823/
https://www.ncbi.nlm.nih.gov/pubmed/31548534
http://dx.doi.org/10.3390/antib6040019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698823/
https://www.ncbi.nlm.nih.gov/pubmed/31548534
http://dx.doi.org/10.3390/antib6040019

Ejemplares similares